D1 Thal (200 mg) + dex (40 mg) |
D2 |
D3 |
D4 |
D5 |
D6 |
D7 |
D8 |
D9 |
D10 |
D11 |
D12 |
D13 |
D14 |
D15 |
D16 |
D17 |
D18 |
D19 |
D20 |
D21 |
D22 |
D23 |
D24 |
D25 |
D26 |
D27 |
D28 |
|
Thal-Dex |
Dex Alone |
||
Side Effect |
Mild or Moderate |
Severe |
Mild or Moderate |
Severe |
Peripheral neuropathy |
51% |
3% |
34% |
0 |
Constipation |
50% |
-- |
21% |
-- |
Swelling in the limbs |
34% |
-- |
25% |
-- |
Weakness, lack of strength/energy |
24% |
5% |
20% |
2% |
Dizziness |
22% |
-- |
14% |
-- |
Fatigue |
22% |
5% |
16% |
4% |
Headache |
18% |
-- |
20% |
-- |
Insomnia |
18% |
-- |
27% |
-- |
Anemia |
16% |
6% |
13% |
3% |
Fever |
16% |
-- |
18% |
-- |
High level of blood sugar (hyperglycemia) |
15% |
6% |
14% |
5% |
If You Have |
Your Doctor May |
Drowsiness |
Adjust the schedule or dose. |
Peripheral neuropathy |
Reduce dose when the symptoms begin; if symptoms don’t progress, maintain reduced dose. |
Dizziness |
Tell you to avoid sudden change in position from lying or sitting to standing. |
Slow pulse |
Reduce the dose or stop the drug if heart rate becomes very low or is associated with tiredness or dizziness. |
Constipation |
Tell you to increase fluid intake. |
Dry skin/rash |
Tell you to use lotion for dry skin. |
|
Thalomid (daily dose) |
Dexamethasone* |
||
Outcome |
(100 mg) |
(200 mg) |
(400 mg) |
(40 mg) |
Time to disease progression (mos.) |
6.7 |
7.3 |
9.9 |
6.0 |
Duration of response (mos.) |
12.7 |
13.1 |
11.6 |
6.5 |
1-yr. overall survival (%) |
80 |
83 |
82 |
80 |
*Dexamethasone was taken on days 1-4, 9-12, and 17-20 of four 28-day treatment
cycles and then on days 1-4 from the fifth treatment cycle on.